Valuation: Eckert & Ziegler SE

Market Cap 77Cr 88Cr 73Cr 67Cr 124.4Cr 8.44TCr 125.37Cr 874.95Cr 339.06Cr 4.3TCr 330.15Cr 322.98Cr 14TCr P/E 2026 *
15.1x
P/E 2027 * 14.3x
Enterprise Value 66Cr 75Cr 62Cr 57Cr 105.78Cr 7.18TCr 106.61Cr 744Cr 288.31Cr 3.65TCr 280.73Cr 274.64Cr 12TCr EV / Sales 2026 *
2.07x
EV / Sales 2027 * 1.9x
Free-Float
67.36%
Yield 2026 *
1.7%
Yield 2027 * 1.74%
1 day-9.48%
Current month-9.48%
1 month-9.48%
3 months-17.71%
1 month 11.82
Extreme 11.824
11.85
Current year 11.82
Extreme 11.824
14.67
1 year 11.82
Extreme 11.824
14.67
3 years 11.82
Extreme 11.824
14.67
5 years 11.82
Extreme 11.824
14.67
10 years 11.82
Extreme 11.824
14.67
Manager TitleAgeSince
Chief Executive Officer 59 07/06/2023
Chief Tech/Sci/R&D Officer - 01/01/2025
Chief Operating Officer 59 01/01/2025
Director TitleAgeSince
Chairman 57 07/06/2023
Director/Board Member 66 01/01/2014
Director/Board Member 58 01/01/2017
Change 5-day change 1-year change 3-year change Capi.($)
-9.48%0.00% - - 88Cr
+4.86%+9.45%+26.33%-16.55% 1.8TCr
-5.20%-1.65%-40.51%+23.38% 195.1Cr
-1.54%+1.16%-32.35%+22.85% 88Cr
+0.11%-0.38%+50.65%-2.64% 78Cr
+3.38%-3.61%-59.95%-85.06% 71Cr
-0.69%+8.73%-29.95%-46.60% 69Cr
+1.77%+2.48%-36.80%-51.24% 58Cr
+5.30%+4.92%+52.38%+90.41% 45Cr
-0.95%+1.96%-6.83%+0.85% 40Cr
Average -0.25%+3.11%-8.56%-7.18% 272.15Cr
Weighted average by Cap. +2.59%+3.65%+14.02%-12.90%

Financials

2026 *2027 *
Net sales 32Cr 36Cr 30Cr 27Cr 51Cr 3.47TCr 52Cr 359.72Cr 139.39Cr 1.77TCr 135.73Cr 132.79Cr 5.75TCr 34Cr 39Cr 32Cr 29Cr 55Cr 3.73TCr 55Cr 386.67Cr 149.84Cr 1.9TCr 145.9Cr 142.74Cr 6.18TCr
Net income 5.17Cr 5.88Cr 4.87Cr 4.44Cr 8.31Cr 563.99Cr 8.38Cr 58Cr 23Cr 287.04Cr 22Cr 22Cr 934.06Cr 5.31Cr 6.04Cr 5Cr 4.57Cr 8.54Cr 579.33Cr 8.6Cr 60Cr 23Cr 294.84Cr 23Cr 22Cr 959.46Cr
Net Debt -12Cr -13Cr -11Cr -9.96Cr -19Cr -1.26TCr -19Cr -130.96Cr -51Cr -642.97Cr -49Cr -48Cr -2.09TCr -12Cr -14Cr -12Cr -11Cr -20Cr -1.34TCr -20Cr -138.58Cr -54Cr -680.4Cr -52Cr -51Cr -2.21TCr
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,105
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.36EUR
Average target price
21.60EUR
Spread / Average Target
+74.76%

Annual profits - Rate of surprise